The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of golimumab (Schering-Plough/Centocor) to submit evidence for the clinical and cost effectiveness of this drug for the treatment of active and progressive psoriatic arthritis (PsA) in patients who have responded...
Atzeni, FTuriel, MBoccassini, LSitia, STomasoni, LBattellino, MMarchesoni, Ade Gennaro Colonna, VSarziPuttini, P
Infliximab in treatment of severe psoriatic arthritis. [Spanish, English] Infliximab no tratamento da artrite psoriasica graveConsorte Loyola, A JWirth Chaibub, S CMiranda De Castro, L CXimenes, A CLoyola AJC, Castro LCM, Chaibub SCW, Ximenes AC. Infliximab in treatmen...